Phase
Condition
Coronary Artery Disease
Chest Pain
Heart Disease
Treatment
[O-15]-Water PET Myocardial Perfusion Imaging (MPI)
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male and female participants ≥18 years;
Informed consent form (ICF) read, signed, and dated prior to any study proceduresbeing performed;
Participants who fall into any one of the following categories:
Have been referred for an ICA directly of after non-invasive testing (e.g.,SPECT or PET MPI, stress echo, CCTA, ETT).
Had an ICA with no intervention. However, if any stenosis >40% but ≤70% wasobserved, an FFR or iFR assessment was performed.
Had a CCTA with normal coronaries or minimal CAD (no stenosis >25%). The SPECT study, PET 15O-H2O study, and ICA or CCTA testing need to be completedwithin a 30-day window, with time 0 defined as the date of the first of these threetests.
Women of Child Bearing Potential (WOCBP) must be non-pregnant, and non-lactating.For women of childbearing potential, the results of a urine human chorionicgonadotropin (HCG) pregnancy test (with the result known on the day of drugadministration) must be negative; these participants must be practicing appropriatebirth control from time of the screening visit until the end of the follow-upperiod. For women who are either surgically sterile (have a documented bilateraltubal ligation or oophorectomy and/or hysterectomy) or are post-menopausal (cessation of menses for more than 1 year), enrollment in the study without apregnancy test at screening is allowed.
Male will need to use contraceptive methods until end of the follow-up period.
Participants are able to comply with all study procedures as described in theprotocol.
Exclusion
Exclusion Criteria:
Participants are unable to undergo (even partially) any of the imaging procedures;
Participants with a known history of cardiac disease including:
myocardial infarction, previous coronary revascularization, or chronic ischemiccardiomyopathy
primary myocardial disease such as cardiac amyloidosis or hypertrophiccardiomyopathy
known left ventricular dysfunction
moderate or severe aortic or mitral stenosis or regurgitation
Participants in whom adenosine stress testing is contraindicated, including but notlimited to:
Participants with severe COPD or chronic asthma.
Participants with second- or third-degree atrioventricular block without apacemaker.
Participants with claustrophobia to an extent that would limit their ability toundergo SPECT and PET imaging (patients whose claustrophobia is known to be readilycontrolled with drugs or psychological support may be enrolled).
Participants who are on sildenafil (Viagra) or oral dipyridamole (Persantine,Aggrenox) therapy or on any PDE5 inhibitor (i.e. tadalafil, avanafil,vardenafil),and for whom its use cannot be terminated or suspended for ≥24 hoursprior to treatment of study drug.
Participants with significant co-morbidities that would prevent appropriatecompletion of the protocol procedures.
Participants who have participated in another research study using investigationaldrugs within the 30 days prior to enrollment or through the duration of the trial (patients in observational studies with approved agents and participants known to beon placebo may be enrolled).
Participants who have previously participated in this study.
Subjects scheduled for, or planning to undergo, any interventional cardiacprocedures between enrollment and ICA (pathway 1) or signing of informed consent and 15O-H2O PET MPI (pathway 2 and 3)
Study Design
Connect with a study center
University of Ottawa Heart Institute
Ottawa, Ontario
CanadaSite Not Available
Aarhus University Hospital
Aarhus N,
DenmarkActive - Recruiting
Sahlgrenska University Hospital
Gothenburg,
SwedenActive - Recruiting
Norrland University Hospital Heart Center
Umeå,
SwedenSite Not Available
University of Iowa
Iowa City, Iowa 52242
United StatesActive - Recruiting
BAMF Healthcare
Grand Rapids, Michigan 49503
United StatesActive - Recruiting
Mayo Clinic
Rochester, Minnesota 55905
United StatesActive - Recruiting
Washington University
Saint Louis, Missouri 63110
United StatesActive - Recruiting
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania 15213
United StatesActive - Recruiting
UT Southwestern Medical Center
Dallas, Texas 75390
United StatesActive - Recruiting
University of Virginia Medical Center
Charlottesville, Virginia 22903
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.